The role and efficacy of clozapine treatment in early-onset and very early-onsetschizophrenia cases: discussion of five cases

While the four cases showing good responses to thetreatment tolerated clozapine well, the other case (case 4) showed an apparent decreasing trendin neutrophil count a short while after starting the treatment and his medication was stoppedat the request of his parents.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Schizophrenia is a serious mental disorder emerging at an early age, characterized by significantbreakdowns in thought, perception and behavioral processes and withdrawal from humanrelationships.

📊

Key Findings & Data:Psychopharmacologic and psychosocial approaches should be combined for thetreatment of schizophrenia.

💡

Conclusion & Impact:While the four cases showing good responses to thetreatment tolerated clozapine well, the other case (case 4) showed an apparent decreasing trendin neutrophil count a short while after starting the treatment and his medication was stoppedat the request of his parents.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Schizophrenia is a serious mental disorder emerging at an early age, characterized by significantbreakdowns in thought, perception and behavioral processes and withdrawal from humanrelationships. Psychopharmacologic and psychosocial approaches should be combined for thetreatment of schizophrenia. Although the effects and side effects of both typical and atypicalantipsychotics have been studied in adult patients in detail, studies in child and adolescentage groups are inadequate. Clozapine is a prototype of atypical antipsychotics and the firstantipsychotic to be defined as atypical. Clozapine is often effective in cases in which typicaland other atypical antipsychotics fail, and is accepted as the gold standard in the treatmentof schizophrenia. In this paper, the effects and side effects of clozapine in five adolescentcases diagnosed with schizophrenia are discussed. Four of these cases showed that clozapineis effective in adolescent schizophrenia. While the four cases showing good responses to thetreatment tolerated clozapine well, the other case (case 4) showed an apparent decreasing trendin neutrophil count a short while after starting the treatment and his medication was stoppedat the request of his parents.

🔖

Cite This Article

YAZICI, K. U., PERÇİNEL, İ., KÖSE, S. G., ZEMLA, J., DONUK, T., İDRİS, B., ÖZBARAN, B., ERERMİŞ, H. S. (2022). The role and efficacy of clozapine treatment in early-onset and very early-onsetschizophrenia cases: discussion of five cases. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 1, 65–73. https://ajindex.com/articles/574368

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (4)

Ozatalay E. Childhood-onset schizophrenia. In: Cuhadaroglu F, Coskun A, Pehlivanturk B, Iseri E, Turkbay T, Miral S, Uslu R, Mukaddes NM, Unal F (editors). Textbook of Child and Adolescent Psychiatry. 1 st ed. Ankara: Hekimler Yayın Birliği; 2008; p. 488-502. (Turkish
Asarnow RF, Asarnow JR. Childhood-onset schizophrenia: editors introduction. Schizophr Bull 1994;20(4):591-7. [CrossRef] 3. Werry JS. Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. J Autism Dev Disord 1992;22(4):601-24. [CrossRef] 4. Gorwood P, Leboyer M, Jay M, Payan C, Feingold J. Gender and age at onset in schizophrenia: impact of family history. Am J Psychiatry 1995;152(2):208-12. [CrossRef] 5. McClellan JM, Werry JS, Ham M. A follow-up study of early- onset psychosis: comparison between outcome diagnoses of schizophrenia, mood disorders, and personality disorders. J Autism Dev Disord 1993;23(2):243-62. [CrossRef] 6. Stahl SM. Stahls Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 3 rd ed. New York: Cambridge University Press, 2008
Van Kammen DP, Marder SP. Serotonin-Dopamine Antagonists. In: Sadock BJ, Sadock VA, (editors). Kaplan & Sadocks Comprehensive Textbook of Psychiatry, Vol 2, 7th ed. Philadelphia: Lipincott Williams & Wilkins, 2000. p. 2455-74
Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, et al. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996;53(12):1090-7. [CrossRef] 9. Masi G, Mucci M, Pari C. Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs 2006;20(10):841-66. [CrossRef] 10. Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, De Thomas C, Kafantaris V, et al. Clozapine and high-dose olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry 2008;63(5):524-9. [CrossRef] 11. Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, et al. Hematological adverse events in clozapine-treated children and adolescents. J Am Acad Child Adolesc Psychiatry 2005;44(10):1024-31. [CrossRef] 12. Maher KN, Tan M, Tossell JW, Weisinger B, Gochman P, Miller R, et al. Risk factors for neutropenia in clozapine- treated children and adolescents with childhood- onset schizophrenia. J Child Adolesc Psychopharmacol 2013;23(2):110-6. [CrossRef] 13. Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychoph